Sprint Bioscience

SPRINT-SE:OME

Pharmaceuticals: Major

Market Cap

—

MICRO cap

Share Price ←

(—)

YTD Return ←

—

since start of 2021

P/E Ratio

—

Corporate Values

Carbon Footprint
Pollution Prevention
Water Conservation
Data & Privacy Protection
Consumer Health, Wellness & Safety
Employee Ownership, Satisfaction, Benefits & Pay
Workplace Health and Safety
Integrity of Corporate Governance
Ethical Practices
Usage of Conflict Materials
Forced Labor
Diversity of Corporate Leadership

About

Pharmaceuticals: Major Founded 2009

Sprint Bioscience AB engages in the business of drug development. It develops medicines in the field of cancer and metabolism. The firm serves as preclinical part of the development process. It works for cancer metabolism and lipid signaling through molecules discovery pipeline within the oncology therapeutics which include protein science, fragment screening, medicinal chemistry, x-ray crystallography, biochemical and cellular test models. The company was founded by Anders Aberg, Par Nordlund, Martin Andersson, Jessica Martinsson, and Kenth Hallberg in 2009 and is headquartered in Huddinge, Sweden.

website

Headquarters

8th Floor

Hälsovägen 7

Huddinge, Stockholm 141 57

46.8.4114455

Executives

Name	Title	Gender
Anders berg, PhD	Chief Executive Officer	Male
Pr Nordlund	Director	Male
Nils Rune Nordlander, EMBA	Chairman	Male
Martin Andersson, PhD	Head-Biology	Male
Kenth Hallberg, PhD	Founder	Male
Jessica Martinsson	Director & Head-Medicinal Chemistry	Female

Mindful Investing Summary

Carbon Footprint

— N/A
Pollution Prevention

— N/A
Water Conservation

— N/A
Data & Privacy Protection

— N/A
Consumer Health, Wellness & Safety

— N/A
Employee Ownership, Satisfaction, Benefits & Pay

— N/A
Workplace Health and Safety

— N/A
Integrity of Corporate Governance

— N/A
Ethical Practices

— N/A
Usage of Conflict Materials

— N/A
Forced Labor

— N/A
Diversity of Corporate Leadership

— N/A

Sprint Bioscience - Competitors and Related Companies

How Sprint Bioscience stacks up to its peers in the Pharmaceuticals: Major industry or with competing business segments.